Philip Phillips is President of PHILLIPS CONSULTING GROUP, LLC. He has 32 years of experience in FDA regulation of medical devices, having focused on the development and implementation of numerous regulatory strategies regarding the design, manufacture and marketing of medical devices in the US. Mr. Phillips brings an in-depth knowledge of a wide range of regulatory matters, including FDA jurisdiction, device classification, clinical trials, and product labeling, including promotion and advertising. During his 24-year FDA tenure, Mr. Phillips streamlined the medical device review processes and launched numerous agency initiatives aimed at enhancing public health while lessening regulatory burden. In addition to serving as the Office of Device Evaluation’s Deputy Director for Science and Regulatory Policy for 12 years, he served as Director of Program Operations, Interim Director for the Division of General and Restorative Devices, Deputy Director for the Division of Ophthalmic Devices and the Chief of the Surgical and Diagnostics Devices Branch in DOD. Mr. Phillips holds a BS in Microbiology from the University of Maryland and a MBA from the George Washington University.